MedTrace Logo

D1 vs D2 Lymphadenectomy in Gastric Cancer

NCT05253430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 357

Last updated 2022-02-23

No results posted yet for this study

Summary

This study is a retrospective study with a propensity score-matched analysis in order to balance differences between patients with D1 and D2 lymphadenectomy for gastric cancer.The main aim is to analyse differences in the postoperative and oncological outcomes of patients with gastric cancer (GC) who underwent D1 and D2 gastrectomy.

Conditions

Interventions

PROCEDURE

Lymphadenectomy type

D1 vs D2 lymph node dissection

Sponsors & Collaborators

  • Fundación para la Investigación del Hospital Clínico de Valencia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-04-30
Primary Completion
2019-10-31
Completion
2021-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253430 on ClinicalTrials.gov